Trial: 202103003

A Phase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly-Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND# 145355)

Phase

II

Principal Investigator

Cluster, Andrew

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov